Clinical and Translational Imaging

, Volume 6, Issue 2, pp 91–100 | Cite as

Sentinel node biopsy in endometrial cancer: an update

  • Cinzia Crivellaro
  • Lucia Baratto
  • Carlotta Dolci
  • Elena De Ponti
  • Sonia Magni
  • Federica Elisei
  • Andrea Papadia
  • Alessandro Buda
Part of the following topical collections:
  1. Genitourinary



A review was conducted to update the recent published literature on sentinel lymph-node (SLN) procedures in endometrial cancer.

Materials and methods

A comprehensive literature search was performed in PubMed and Cochrane library, searching from English language publication of the last 10 years about sentinel lymph node (SLN) in endometrial cancer. Eligible studies had a sample size > 30 patients and reported at least the detection rate. Detection rate, bilateral mapping rate, sensitivity (SN), and negative predictive value (NPV) were evaluated. Different techniques were assessed both for detection rate and for bilateral mapping. A subgroup analysis on studies focused on SPET was performed.


Forty studies were considered for the analysis (6162 patients). The overall detection rate of SLN mapping was 87.7% (95% CI 77.6–97.9%, range 62–100%). The pooled bilateral mapping rate was 59.9% (95% CI 43.2–76.6%, range 21–92%). The pooled SN resulted 98.3% (range: 50–100%) and the pooled NPV was 99.5% (range 86–100%). Cervical injection was the most used technique. Indocyanine green (ICG) and the combination of radiotracer/blue dye resulted in the highest SLN detection rates: 95% (95% CI 86–100%) and 90% (95% CI 79–100%) with cervical injection, respectively. ICG demonstrated the highest values of bilateral nodal mapping 75% (95% CI 60–91%) with cervical injection. Studies focused on SPET/CT showed a low/moderate correlation between SPET imaging and intraoperative findings.


SLN mapping accurately predicts nodal status in women with endometrial cancer. Future prospective evaluation of prognosis/outcome is needed to define the impact of this technique for personalized therapy.


Sentinel node Endometrial cancer Review Indocyanine green Blue dye SPET 


Compliance with ethical standards

Conflict of interest

C. Crivellaro, L. Baratto, C. Dolci, E. De Ponti, S. Magni, F. Elisei, A. Papadia, and A. Buda declare no conflict of interest.


  1. 1.
    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRefPubMedGoogle Scholar
  2. 2.
    Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658):125–136CrossRefPubMedGoogle Scholar
  3. 3.
    Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100(23):1707–1716CrossRefPubMedGoogle Scholar
  4. 4.
    Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C (2013) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi33–vi38CrossRefPubMedGoogle Scholar
  5. 5.
    May K, Bryant A, Dickinson HO, Kehoe S, Morrison J (2010) Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev.
  6. 6.
    Crivellaro C, Signorelli M, Guerra L, De Ponti E, Pirovano C, Fruscio R, Elisei F, Montanelli L, Buda A, Messa C (2013) Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Gynecol Oncol 130(2):306–311CrossRefPubMedGoogle Scholar
  7. 7.
    Signorelli M, Crivellaro C, Buda A, Guerra L, Fruscio R, Elisei F, Dolci C, Cuzzocrea M, Milani R, Messa C (2015) Staging of high-risk endometrial cancer with PET/CT and sentinel lymph node mapping. Clin Nucl Med 40(10):780–785CrossRefPubMedGoogle Scholar
  8. 8.
    NCCN Clinical Practice Guidelines in Oncology, Uterine Neoplasm; 2017.
  9. 9.
    Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR et al (2016) ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol 27(1):16–41CrossRefPubMedGoogle Scholar
  10. 10.
    Cibula D, Oonk MH, Abu-Rustum NR (2015) Sentinel lymph node biopsy in the management of gynecologic cancer. Curr Opin Obstet Gynecol 27(1):66–72CrossRefPubMedGoogle Scholar
  11. 11.
    Barlin JN, Khoury-Collado F, Kim CH, Leitao MM Jr, Chi DS, Sonoda Y, Alektiar K, DeLair DF, Barakat RR, Abu-Rustum NR (2012) The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol 125(3):531–535CrossRefPubMedGoogle Scholar
  12. 12.
    Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, Soslow RA, Dao F, Sonoda Y, Levine DA, Brown CL, Chi DS, Barakat RR et al (2009) Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol 113(2):163–169CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Baiocchi G, Mantoan H, Kumagai LY, Goncalves BT, Badiglian-Filho L, de Oliveira Menezes AN, Faloppa CC, De Brot L, da Costa A (2017) The impact of sentinel node-mapping in staging high-risk endometrial cancer. Ann Surg Oncol 24(13):3981–3987CrossRefPubMedGoogle Scholar
  14. 14.
    Ballester M, Dubernard G, Lecuru F, Heitz D, Mathevet P, Marret H, Querleu D, Golfier F, Leblanc E, Rouzier R et al (2011) Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 12(5):469–476CrossRefPubMedGoogle Scholar
  15. 15.
    Barranger E, Delpech Y, Coutant C, Dubernard G, Uzan S, Darai E (2009) Laparoscopic sentinel node mapping using combined detection for endometrial cancer: a study of 33 cases–is it a promising technique? Am J Surg 197(1):1–7CrossRefPubMedGoogle Scholar
  16. 16.
    Bats AS, Clement D, Larousserie F, Le Frere-Belda MA, Pierquet-Ghazzar N, Hignette C, Lecuru F (2008) Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. J Surg Oncol 97(2):141–145CrossRefPubMedGoogle Scholar
  17. 17.
    Biliatis I, Thomakos N, Koutroumpa I, Haidopoulos D, Sotiropoulou M, Antsaklis A, Vlachos G, Akrivos N, Rodolakis A (2017) Subserosal uterine injection of blue dye for the identification of the sentinel node in patients with endometrial cancer: a feasibility study. Arch Gynecol Obstet 296:565–570CrossRefPubMedGoogle Scholar
  18. 18.
    Blakely M, Liu Y, Rahaman J, Prasad-Hayes M, Tismenetsky M, Wang X, Nair N, Dresser KA, Nagarsheth N, Kalir T (2017) Sentinel lymph node ultra-staging as a supplement for endometrial cancer intraoperative frozen section deficiencies. Int J Gynecol Pathol 0:1–7CrossRefGoogle Scholar
  19. 19.
    Clinton LK, Kondo J, Carney ME, Tauchi-Nishi P, Terada K, Shimizu D (2017) Low-volume lymph node metastases in endometrial carcinoma. Int J Gynecol Cancer 27(6):1165–1170CrossRefPubMedGoogle Scholar
  20. 20.
    Desai PH, Hughes P, Tobias DH, Tchabo N, Heller PB, Dise C, Slomovitz BM (2014) Accuracy of robotic sentinel lymph node detection (RSLND) for patients with endometrial cancer (EC). Gynecol Oncol 135(2):196–200CrossRefPubMedGoogle Scholar
  21. 21.
    Elisei F, Crivellaro C, Giuliani D, Dolci C, De Ponti E, Montanelli L, La Manna M, Guerra L, Arosio M, Landoni C et al (2017) Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye. Ann Nucl Med 31(1):93–99CrossRefPubMedGoogle Scholar
  22. 22.
    Eriksson AG, Montovano M, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, Gardner GJ, Zivanovic O, Barakat RR, Brown CL et al (2016) Impact of obesity on sentinel lymph node mapping in patients with newly diagnosed uterine cancer undergoing robotic surgery. Ann Surg Oncol 23(8):2522–2528CrossRefPubMedGoogle Scholar
  23. 23.
    Farghali MM, Allam IS, Abdelazim IA, El-Kady OS, Rashed AR, Gareer WY, Sweed MS (2015) Accuracy of sentinel node in detecting lymph node metastasis in primary endometrial carcinoma. Asian Pac J Cancer Prev 16(15):6691–6696CrossRefPubMedGoogle Scholar
  24. 24.
    Favero G, Pfiffer T, Ribeiro A, Carvalho JP, Baracat EC, Mechsner S, Chiantera V, Kohler C, Schneider A (2015) Laparoscopic sentinel lymph node detection after hysteroscopic injection of technetium-99 in patients with endometrial cancer. Int J Gynecol Cancer 25(3):423–430CrossRefPubMedGoogle Scholar
  25. 25.
    Geppert B, Lonnerfors C, Bollino M, Arechvo A, Persson J (2017) A study on uterine lymphatic anatomy for standardization of pelvic sentinel lymph node detection in endometrial cancer. Gynecol Oncol 145(2):256–261CrossRefPubMedGoogle Scholar
  26. 26.
    Hagen B, Valla M, Aune G, Ravlo M, Abusland AB, Araya E, Sundset M, Tingulstad S (2016) Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm. Gynecol Oncol 143(3):479–483CrossRefPubMedGoogle Scholar
  27. 27.
    Holloway RW, Ahmad S, Kendrick JE, Bigsby GE, Brudie LA, Ghurani GB, Stavitzski NM, Gise JL, Ingersoll SB, Pepe JW (2017) A prospective Cohort Study comparing colorimetric and fluorescent imaging for sentinel lymph node mapping in endometrial cancer. Ann Surg Oncol 24(7):1972–1979CrossRefPubMedGoogle Scholar
  28. 28.
    How J, Boldeanu I, Lau S, Salvador S, How E, Gotlieb R, Abitbol J, Halder A, Amajoud Z, Probst S et al (2017) Unexpected locations of sentinel lymph nodes in endometrial cancer. Gynecol Oncol 147(1):18–23CrossRefPubMedGoogle Scholar
  29. 29.
    Kataoka F, Susumu N, Yamagami W, Kuwahata M, Takigawa A, Nomura H, Takeuchi H, Nakahara T, Kameyama K, Aoki D (2016) The importance of para-aortic lymph nodes in sentinel lymph node mapping for endometrial cancer by using hysteroscopic radio-isotope tracer injection combined with subserosal dye injection: prospective study. Gynecol Oncol 140(3):400–404CrossRefPubMedGoogle Scholar
  30. 30.
    Khoury-Collado F, Murray MP, Hensley ML, Sonoda Y, Alektiar KM, Levine DA, Leitao MM, Chi DS, Barakat RR, Abu-Rustum NR (2011) Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. Gynecol Oncol 122(2):251–254CrossRefPubMedGoogle Scholar
  31. 31.
    Kim CH, Soslow RA, Park KJ, Barber EL, Khoury-Collado F, Barlin JN, Sonoda Y, Hensley ML, Barakat RR, Abu-Rustum NR (2013) Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer 23(5):964–970CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    la Manzanara Lopez-De, Cano C, Cordero Garcia JM, Martin-Francisco C, Pascual-Ramirez J, Parra CP, Cespedes Casas C (2014) Sentinel lymph node detection using 99mTc combined with methylene blue cervical injection for endometrial cancer surgical management: a prospective study. Int J Gynecol Cancer 24(6):1048–1053CrossRefGoogle Scholar
  33. 33.
    Mais V, Peiretti M, Gargiulo T, Parodo G, Cirronis MG, Melis GB (2010) Intraoperative sentinel lymph node detection by vital dye through laparoscopy or laparotomy in early endometrial cancer. J Surg Oncol 101(5):408–412PubMedGoogle Scholar
  34. 34.
    Martinelli F, Ditto A, Signorelli M, Bogani G, Chiappa V, Lorusso D, Scaffa C, Recalcati D, Perotto S, Haeusler E et al (2017) Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: a single center evaluation over 200 cases. Gynecol Oncol 146(3):525–530CrossRefPubMedGoogle Scholar
  35. 35.
    Mucke J, Klapdor R, Schneider M, Langer F, Gratz KF, Hillemanns P, Hertel H (2014) Isthmocervical labelling and SPECT/CT for optimized sentinel detection in endometrial cancer: technique, experience and results. Gynecol Oncol 134(2):287–292CrossRefPubMedGoogle Scholar
  36. 36.
    Naoura I, Canlorbe G, Bendifallah S, Ballester M, Darai E (2015) Relevance of sentinel lymph node procedure for patients with high-risk endometrial cancer. Gynecol Oncol 136(1):60–64CrossRefPubMedGoogle Scholar
  37. 37.
    Paley PJ, Veljovich DS, Press JZ, Isacson C, Pizer E, Shah C (2016) A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging. Am J Obstet Gynecol 215(1):117.e1–117.e7CrossRefGoogle Scholar
  38. 38.
    Papadia A, Zapardiel I, Bussi B, Ghezzi F, Ceccaroni M, De Ponti E, Elisei F, Imboden S, de la Noval BD, Gasparri ML et al (2017) Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99(m) with blue dye versus indocyanine green fluorescent dye. J Cancer Res Clin Oncol 143(3):475–480CrossRefPubMedGoogle Scholar
  39. 39.
    Perrone AM, Casadio P, Formelli G, Levorato M, Ghi T, Costa S, Meriggiola MC, Pelusi G (2008) Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol Oncol 111(1):62–67CrossRefPubMedGoogle Scholar
  40. 40.
    Raimond E, Ballester M, Hudry D, Bendifallah S, Darai E, Graesslin O, Coutant C (2014) Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: results of a retrospective multicenter study. Gynecol Oncol 133(3):506–511CrossRefPubMedGoogle Scholar
  41. 41.
    Robova H, Charvat M, Strnad P, Hrehorcak M, Taborska K, Skapa P, Rob L (2009) Lymphatic mapping in endometrial cancer: comparison of hysteroscopic and subserosal injection and the distribution of sentinel lymph nodes. Int J Gynecol Cancer 19(3):391–394CrossRefPubMedGoogle Scholar
  42. 42.
    Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, Method M, Ade M, Ivanova A, Boggess JF (2017) A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 18(3):384–392CrossRefPubMedGoogle Scholar
  43. 43.
    Sawicki S, Lass P, Wydra D (2015) Sentinel lymph node biopsy in endometrial cancer-comparison of 2 detection methods. Int J Gynecol Cancer 25(6):1044–1050CrossRefPubMedGoogle Scholar
  44. 44.
    Sinno AK, Fader AN, Roche KL, Giuntoli RL 2nd, Tanner EJ (2014) A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer. Gynecol Oncol 134(2):281–286CrossRefPubMedGoogle Scholar
  45. 45.
    Solima E, Martinelli F, Ditto A, Maccauro M, Carcangiu M, Mariani L, Kusamura S, Fontanelli R, Grijuela B, Raspagliesi F (2012) Diagnostic accuracy of sentinel node in endometrial cancer by using hysteroscopic injection of radiolabeled tracer. Gynecol Oncol 126(3):419–423CrossRefPubMedGoogle Scholar
  46. 46.
    Soliman PT, Westin SN, Dioun S, Sun CC, Euscher E, Munsell MF, Fleming ND, Levenback C, Frumovitz M, Ramirez PT et al (2017) A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol 146(2):234–239CrossRefPubMedGoogle Scholar
  47. 47.
    Taskin S, Sukur YE, Altin D, Ersoz CC, Turgay B, Kankaya D, Gungor M, Ortac F (2017) Laparoscopic near-infrared fluorescent imaging as an alternative option for sentinel lymph node mapping in endometrial cancer: a prospective study. Int J Surg 47:13–17CrossRefPubMedGoogle Scholar
  48. 48.
    Torne A, Pahisa J, Vidal-Sicart S, Martinez-Roman S, Paredes P, Puerto B, Albela S, Fuste P, Perisinotti A, Ordi J (2013) Transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR): a new method for sentinel lymph node detection in endometrial cancer. Gynecol Oncol 128(1):88–94CrossRefPubMedGoogle Scholar
  49. 49.
    Touhami O, Gregoire J, Renaud MC, Sebastianelli A, Plante M (2017) Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer. Gynecol Oncol 147(3):549–553CrossRefPubMedGoogle Scholar
  50. 50.
    Vidal F, Leguevaque P, Motton S, Delotte J, Ferron G, Querleu D, Rafii A (2013) Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting. Int J Gynecol Cancer 23(7):1237–1243CrossRefPubMedGoogle Scholar
  51. 51.
    Sahbai S, Taran FA, Fiz F, Staebler A, Becker S, Solomayer E, Wallwiener D, la Fougere C, Brucker S, Dittmann H (2016) Pericervical injection of 99mTc-nanocolloid is superior to peritumoral injection for sentinel lymph node detection of endometrial cancer in SPECT/CT. Clin Nucl Med 41(12):927–932CrossRefPubMedGoogle Scholar
  52. 52.
    Naaman Y, Pinkas L, Roitman S, Ikher S, Oustinov N, Vaisbuch E, Yachnin A, Ben-Arie A (2016) The added value of SPECT/CT in sentinel lymph nodes mapping for endometrial carcinoma. Ann Surg Oncol 23(2):450–455CrossRefPubMedGoogle Scholar
  53. 53.
    Pandit-Taskar N, Gemignani ML, Lyall A, Larson SM, Barakat RR, Abu Rustum NR (2010) Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. Gynecol Oncol 117(1):59–64CrossRefPubMedGoogle Scholar
  54. 54.
    Sahbai S, Taran FA, Staebler A, Wallwiener D, la Fougere C, Brucker S, Dittmann H (2017) Sentinel lymph node mapping using SPECT/CT and gamma probe in endometrial cancer: an analysis of parameters affecting detection rate. Eur J Nucl Med Mol Imaging 44(9):1511–1519CrossRefPubMedGoogle Scholar
  55. 55.
    Sawicki S, Kobierski J, Lapinska-Szumczyk S, Lass P, Cytawa W, Bianek-Bodzak A, Wydra D (2013) Comparison of SPECT-CT results and intraoperative detection of sentinel lymph nodes in endometrial cancer. Nucl Med Commun 34(6):590–596CrossRefPubMedGoogle Scholar
  56. 56.
    Blakely M, Liu Y, Rahaman J, Prasad-Hayes M, Tismenetsky M, Wang X, Nair N, Dresser KA, Nagarsheth N, Kalir T (2017) Sentinel lymph node ultra-staging as a supplement for endometrial cancer intraoperative frozen section deficiencies. Int J Gynecol Pathol. PubMedGoogle Scholar
  57. 57.
    Cormier B, Rozenholc AT, Gotlieb W, Plante M, Giede C (2015) Sentinel lymph node procedure in endometrial cancer: a systematic review and proposal for standardization of future research. Gynecol Oncol 138(2):478–485CrossRefPubMedGoogle Scholar
  58. 58.
    Papadia A, Gasparri ML, Buda A, Mueller MD (2017) Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue. J Cancer Res Clin Oncol 143(10):2039–2048CrossRefPubMedGoogle Scholar
  59. 59.
    Abu-Rustum NR (2014) Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. J Natl Compr Cancer Netw 12(2):288–297CrossRefGoogle Scholar
  60. 60.
    Brar H, Hogen L, Covens A (2017) Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer. Cancer 123(10):1751–1759CrossRefPubMedGoogle Scholar
  61. 61.
    Kieckbusch H, Coldewey SM, Hollenhorst J, Haeseler G, Hillemanns P, Hertel H (2008) Patent blue sentinel node mapping in cervical cancer patients may lead to decreased pulse oximeter readings and positive methaemoglobin results. Eur J Anaesthesiol 25(5):365–368CrossRefPubMedGoogle Scholar
  62. 62.
    Perissinotti A, Paredes P, Vidal-Sicart S, Torne A, Albela S, Navales I, Martinez-Roman S, Pahisa J, Pons F (2013) Use of SPECT/CT for improved sentinel lymph node localization in endometrial cancer. Gynecol Oncol 129(1):42–48CrossRefPubMedGoogle Scholar
  63. 63.
    Buda A, Elisei F, Arosio M, Dolci C, Signorelli M, Perego P, Giuliani D, Recalcati D, Cattoretti G, Milani R et al (2012) Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: our experience and literature review. Int J Gynecol Cancer 22(5):830–835CrossRefPubMedGoogle Scholar
  64. 64.
    Ballester M, Rouzier R, Coutant C, Kerrou K, Darai E (2009) Limits of lymphoscintigraphy for sentinel node biopsy in women with endometrial cancer. Gynecol Oncol 112(2):348–352CrossRefPubMedGoogle Scholar
  65. 65.
    Giammarile F, Bozkurt MF, Cibula D, Pahisa J, Oyen WJ, Paredes P, Olmos RV, Sicart SV (2014) The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers. Eur J Nucl Med Mol Imaging 41(7):1463–1477CrossRefPubMedGoogle Scholar
  66. 66.
    Brucker SY, Taran FA, Wallwiener D (2014) Sentinel lymph node mapping in endometrial cancer: a concept ready for clinical routine? Arch Gynecol Obstet 290(1):9–11CrossRefPubMedGoogle Scholar
  67. 67.
    Buda A, Elisei F, Palazzi S, De Ponti E, Arosio M, Vecchione F, Dell’Anna T, Cuzzocrea M, Bussi B, Giuliani D et al (2016) Quality of care for cervical and endometrial cancer patients: the impact of different techniques of sentinel lymph node mapping on patient satisfaction. Ann Surg Oncol 23(9):2975–2981CrossRefPubMedGoogle Scholar
  68. 68.
    Buda A, Crivellaro C, Elisei F, Di Martino G, Guerra L, De Ponti E, Cuzzocrea M, Giuliani D, Sina F, Magni S et al (2015) Impact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: comparison with conventional radiotracer Tc and/or blue dye. Ann Surg Oncol 23(7):2183–2191CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Lin H, Ding Z, Kota VG, Zhang X, Zhou J (2017) Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Oncotarget 8(28):46601–46610PubMedPubMedCentralGoogle Scholar
  70. 70.
    How JA, O’Farrell P, Amajoud Z, Lau S, Salvador S, How E, Gotlieb WH (2017) Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Minerva Ginecol 70(2):194–214PubMedGoogle Scholar
  71. 71.
    Bodurtha Smith AJ, Fader AN, Tanner EJ (2017) Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol 216(5):459–476CrossRefPubMedGoogle Scholar
  72. 72.
    Ruscito I, Gasparri ML, Braicu EI, Bellati F, Raio L, Sehouli J, Mueller MD, Panici PB, Papadia A (2016) Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes-a meta-analysis. Ann Surg Oncol 23(11):3749–3756CrossRefPubMedGoogle Scholar
  73. 73.
    Khoury-Collado F, St Clair C, Abu-Rustum NR (2016) Sentinel lymph node mapping in endometrial cancer: an update. Oncologist 21(4):461–466CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    St Clair CM, Eriksson AG, Ducie JA, Jewell EL, Alektiar KM, Hensley ML, Soslow RA, Abu-Rustum NR, Leitao MM Jr (2016) Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma. Ann Surg Oncol 23(5):1653–1659CrossRefPubMedGoogle Scholar
  75. 75.
    Plante M, Stanleigh J, Renaud MC, Sebastianelli A, Grondin K, Gregoire J (2017) Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: does adjuvant treatment matter? Gynecol Oncol 146(2):240–246CrossRefPubMedGoogle Scholar

Copyright information

© Italian Association of Nuclear Medicine and Molecular Imaging 2018

Authors and Affiliations

  1. 1.School of Medicine and SurgeryUniversity Milan-BicoccaMilanItaly
  2. 2.Department of Nuclear MedicineASST Monza, San Gerardo HospitalMonzaItaly
  3. 3.Department of Radiology, Division of Nuclear Medicine and Molecular ImagingStanford University Medical CenterStanfordUSA
  4. 4.Department of Medical PhysicsASST Monza, San Gerardo HospitalMonzaItaly
  5. 5.Department of Obstetrics and GynecologyASST Monza, San Gerardo HospitalMonzaItaly
  6. 6.Department of Obstetrics and GynecologyUniversity Hospital of Bern and University of BernBernSwitzerland

Personalised recommendations